![Spacer](https://webarchive.library.unt.edu/eot2008/20090511214243im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090511214243im_/http://www.fda.gov/cvm/Images/dot_clear.gif)
Table of Contents
|
![Spacer](https://webarchive.library.unt.edu/eot2008/20090511214243im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
![Spacer](https://webarchive.library.unt.edu/eot2008/20090511214243im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
These letters are supplied by the Center for Veterinary Medicine’s (CVM) Freedom of Information Staff. These Regulatory Activity Letters are issued by the Division of Surveillance, in CVM’s Office of Surveillance and Compliance. For District Office Warning Letters see the FDA FOI Warning Letters Page. Some of the letters have been redacted or edited to remove confidential information.
Matters described in these Regulatory Activity Letters may have been subject to subsequent interaction between FDA and the recipient of the letter that may have changed the regulatory status of the issues discussed in the letter. If you wish to obtain available additional information on the current status of an issue in a particular Regulatory Activity Letter, please contact the FDA’s Freedom of Information Office or the addressee in the letter directly. Inquiries to FDA should be sent to: Food and Drug Administration, Freedom of Information Staff (HFI-35), 5600 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found on FDA's website.
The free Adobe Acrobat Reader is needed to review PDF files.
Web Page Updated by hd - December 5, 2006, 11:34 AM ET
|
![Spacer](https://webarchive.library.unt.edu/eot2008/20090511214243im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |